{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T05:06:04Z","timestamp":1741496764740,"version":"3.38.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03986-6","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T14:30:42Z","timestamp":1741444242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative study between botulinum toxin and topical steroid in treatment of psoriasis vulgaris"],"prefix":"10.1007","volume":"317","author":[{"given":"Amel Raouf","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai Tarek","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha","family":"Ezzat Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"issue":"3","key":"3986_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ncrna.2023.04.002","volume":"8","author":"R Erfan","year":"2023","unstructured":"Erfan R, Shaker OG, Khalil MAF, AlOrbani AM, Abu-El-Azayem AK, Samy A, Zaki OM, Abdelhamid H, Fares R, Mohammed A (2023) Lnc-HULC, miR-122, and sirtulin-1 as potential diagnostic biomarkers for psoriasis and their association with the development of metabolic syndrome during the disease course. Non-coding RNA Res 8(3):340\u2013349","journal-title":"Non-coding RNA Res"},{"issue":"6","key":"3986_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.25259\/IJDVL_243_2021","volume":"88","author":"MH El-Komy","year":"2022","unstructured":"El-Komy MH, Ahmed H, Mourad A, Shaker OG, AlOrbani AM (2022) Interleukin 27 in psoriasis: friend or foe? Indian J Dermatol Venereol Leprol 88(6):843\u2013845","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"3986_CR3","first-page":"278","volume":"63","author":"WB Kim","year":"2017","unstructured":"Kim WB, Jerome D, Yeung J (2017) Diagnosis and management of psoriasis. Can Family Physician Medecin De Famille Canadien 63(4):278\u2013285","journal-title":"Can Family Physician Medecin De Famille Canadien"},{"issue":"4","key":"3986_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/2229-5178.209622","volume":"8","author":"R Torsekar","year":"2017","unstructured":"Torsekar R, Gautam MM (2017) Topical therapies in Psoriasis. Indian Dermatology Online J 8(4):235\u2013245","journal-title":"Indian Dermatology Online J"},{"issue":"3","key":"3986_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5114\/ada.2021.108445","volume":"39","author":"B Zhu","year":"2022","unstructured":"Zhu B, Jing M, Yu Q, Ge X, Yuan F, Shi L (2022) Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy. Postepy Dermatologii i Alergologii 39(3):460\u2013471","journal-title":"Postepy Dermatologii i Alergologii"},{"issue":"6","key":"3986_CR6","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis Pathogenesis and Treatment. Int J Mol Sci 20(6):1475","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3986_CR7","doi-asserted-by":"publisher","first-page":"BSR20181335","DOI":"10.1042\/BSR20181335","volume":"39","author":"OG Shaker","year":"2019","unstructured":"Shaker OG, Mahmoud RH, Abdelaleem OO, Ibrahem EG, Mohamed AA, Zaki OM, Abdelghaffar NK, Ahmed TI, Hemeda NF, Ahmed NA, Mansour DF (2019) LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis. Biosci Rep 39(1):BSR20181335","journal-title":"Biosci Rep"},{"issue":"3","key":"3986_CR8","doi-asserted-by":"publisher","first-page":"xv","DOI":"10.1016\/j.det.2024.04.001","volume":"42","author":"JM Cohen","year":"2024","unstructured":"Cohen JM (2024) Psoriasis in 2024 and Beyond. Dermatol Clin 42(3):xv\u2013xvi","journal-title":"Dermatol Clin"},{"issue":"5","key":"3986_CR9","first-page":"297","volume":"101","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C, Pathy AL (2020) Systemic pharmacologic treatments for Plaque psoriasis: a review. Am Family Phys 101(5):297\u2013306","journal-title":"Am Family Phys"},{"issue":"7","key":"3986_CR10","first-page":"CD011535","volume":"7","author":"E Sbidian","year":"2023","unstructured":"Sbidian E, Chaimani A, Guelimi R, Garcia-Doval I, Hua C, Hughes C, Naldi L, Kinberger M, Afach S, Le Cleach L (2023) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev 7(7):CD011535","journal-title":"Cochrane Database Syst Rev"},{"key":"3986_CR11","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez C, Franco M, Londo\u00f1o A, Valenzuela F (2020) Breaking paradigms in the treatment of psoriasis: use of botulinum toxin for the treatment of plaque psoriasis. Dermatol Ther, 33(6), e14319","DOI":"10.1111\/dth.14319"},{"issue":"1","key":"3986_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000452341","volume":"3","author":"A Campanati","year":"2017","unstructured":"Campanati A, Martina E, Giuliodori K, Consales V, Bobyr I, Offidani A (2017) Botulinum Toxin off-label use in Dermatology: a review. Skin Appendage Disorders 3(1):39\u201356","journal-title":"Skin Appendage Disorders"},{"issue":"6","key":"3986_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jaad.2018.07.058","volume":"79","author":"KA Aschenbeck","year":"2018","unstructured":"Aschenbeck KA, Hordinsky MK, Kennedy WR, Wendelschafer-Crabb G, Ericson ME, Kavand S, Bertin A, Dykstra DD, Panoutsopoulou IG (2018) Neuromodulatory treatment of recalcitrant plaque psoriasis with onabotulinumtoxinA. J Am Acad Dermatol 79(6):1156\u20131159","journal-title":"J Am Acad Dermatol"},{"key":"3986_CR14","doi-asserted-by":"crossref","unstructured":"Ayasse MT, Buddenkotte J, Alam M, Steinhoff M Role of neuroimmune circuits and pruritus in psoriasis. Experimental dermatology, 29(4), 414\u2013426.AND (, Martina E, Diotallevi F, Radi G, Campanati A, Offidani A (2020) (2021). Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review. Toxins, 13(2), 120","DOI":"10.1111\/exd.14071"},{"issue":"2","key":"3986_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/toxins13020120","volume":"13","author":"E Martina","year":"2021","unstructured":"Martina E, Diotallevi F, Radi G, Campanati A, Offidani A (2021) Therapeutic use of Botulinum neurotoxins in Dermatology. Syst Rev Toxins 13(2):120","journal-title":"Syst Rev Toxins"},{"key":"3986_CR16","doi-asserted-by":"crossref","unstructured":"Martin M, Okun FHC; Yihua Gu, AbbVie Inc.; Xin Huang, AbbVie Inc.; Yan Sun, AbbVie Inc.; Piyalal Karunaratne, AbbVie Inc.;, Wendell C, Valdecantos, AbbVie Inc (2017). Psoriasis Area Severity Index (PASI) assessment of a single body region to represent achievement of PASI 75 and 90 responses with adalimumab. Journal of the American Academy of Dermatology, ISSN: 0190\u20139622, Vol: 76, Issue: 6, Page: AB208","DOI":"10.1016\/j.jaad.2017.04.811"},{"issue":"1","key":"3986_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/jfmpc.jfmpc_689_19","volume":"9","author":"JP Rajguru","year":"2020","unstructured":"Rajguru JP, Maya D, Kumar D, Suri P, Bhardwaj S, Patel ND (2020) Update on psoriasis: a review. J Family Med Prim Care 9(1):20","journal-title":"J Family Med Prim Care"},{"issue":"3","key":"3986_CR18","first-page":"230","volume":"58","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Liu Z, Huang L (2024) The potential of Botulinum toxin type A in dermatological treatments: a review of efficacy and safety in psoriasis. Dermatology Rev 58(3):230\u2013236","journal-title":"Dermatology Rev"},{"issue":"4","key":"3986_CR19","first-page":"512","volume":"45","author":"S Patel","year":"2023","unstructured":"Patel S, Sharma A, Kapoor M (2023) Botulinum toxin for psoriasis: short-term efficacy and long-term safety considerations. J Clin Dermatology 45(4):512\u2013519","journal-title":"J Clin Dermatology"},{"issue":"2","key":"3986_CR20","first-page":"145","volume":"27","author":"A Smith","year":"2022","unstructured":"Smith A, Taylor R, Wong B (2022) Long-term effects of Botulinum toxin injections in chronic psoriasis management. Psoriasis Res J 27(2):145\u2013150","journal-title":"Psoriasis Res J"},{"key":"3986_CR21","unstructured":"Gabros S, Nessel TA, Zito PM (2023) Topical corticosteroids. StatPearls. StatPearls Publishing"},{"issue":"10","key":"3986_CR22","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1111\/jocd.14306","volume":"20","author":"FM Khattab","year":"2021","unstructured":"Khattab FM, Samir MA (2021) Botulinum toxin type-A versus 5-fluorouracil in the treatment of plaque psoriasis: comparative study. J Cosmet Dermatol 20(10):3128\u20133132","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"3986_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/medicina58060813","volume":"58","author":"MN Popescu","year":"2022","unstructured":"Popescu MN, Beiu C, Iliescu MG, Mihai MM, Popa LG, St\u0103nescu AMA, Berteanu M (2022) Botulinum toxin use for modulating neuroimmune cutaneous activity in psoriasis. Medicina 58(6):813","journal-title":"Medicina"},{"issue":"4","key":"3986_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1468-3083.2007.02457.x","volume":"22","author":"M Zanchi","year":"2008","unstructured":"Zanchi M, Favot F, Bizzarini M, Piai M, Donini M, Sedona P (2008) Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol 22(4):431\u2013436","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03986-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03986-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03986-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T14:30:47Z","timestamp":1741444247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03986-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3986"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03986-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by Faculty of Medicine, Fayoum University, approval number M606 on approval date 12\/06\/2022. A written informed consent was obtained for participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"A written informed consent was obtained for participation in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informal consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"537"}}